plugin.json

{
  "$schema": "https://agent-plugins.org/schemas/1.0.0/plugin.schema.json",
  "name": "rxiq",
  "version": "1.0.0",
  "description": "NHS England primary care prescribing data: spend, trends, measures, Drug Tariff prices and ICB reports.",
  "author": {
    "name": "Andrew Charlwood",
    "email": "contact@rxiq.co.uk",
    "url": "https://rxiq.co.uk"
  },
  "homepage": "https://rxiq.co.uk/connect",
  "keywords": [
    "nhs",
    "prescribing",
    "medicines",
    "pharmacy",
    "drug tariff",
    "icb"
  ],
  "extensions": {
    "com.openai": {
      "interface": {
        "displayName": "RxIQ",
        "shortDescription": "NHS primary care prescribing",
        "longDescription": "RxIQ answers questions about NHS primary care prescribing, from national level down to individual GP practices. It is built for medicines optimisation teams, pharmacists, commissioners, analysts and anyone researching how medicines are prescribed and paid for in England.\n\nAsk about any medicine, BNF section or class of drugs, and about any integrated care board (ICB), sub-ICB area, primary care network (PCN) or GP practice. RxIQ can:\n\n- Query prescribing by medicine, place and month: items, quantity and cost, totals and per 1,000 patients, ranked and split by area or product, for GP or non-GP prescribers.\n- Summarise a medicine: national spend and trend, the ICBs that prescribe most per patient, and its current Drug Tariff price.\n- Profile a place: list size, spend and year-on-year growth for an ICB, PCN or practice.\n- Report clinical measures (antibiotics, opioids, respiratory, diabetes, safety and more), with each place's value, England's value and its rank.\n- Show Drug Tariff price history and price concessions for a pack, with the estimated extra cost to the NHS.\n- Give an ICB's finance position against national benchmarks, its forecast and savings targets.\n- Return the headline and summary of an ICB's monthly prescribing intelligence report, with a link to the full report.\n- Draft a dashboard on rxiq.co.uk from a description, with a link to view it and save a copy.\n\nWhat RxIQ adds to the raw NHSBSA open data: a fast query engine over five years of monthly practice-level prescribing, clinical measures ranked across all 36 ICBs, Drug Tariff and concession history joined to prescribing volumes, need-adjusted finance benchmarks and forecasts, and monthly ICB intelligence reports. Every answer links to the matching page on rxiq.co.uk so figures can be checked.\n\nRxIQ holds aggregate prescribing data published by the NHS Business Services Authority. It holds no patient-level data and does not give clinical advice. Spend figures count GP prescribing unless non-GP prescribing is asked for. No account is needed.",
        "developerName": "Andrew Charlwood",
        "category": "Data & Analytics",
        "capabilities": [
          "Query NHS England prescribing by medicine, area and month",
          "Compare ICBs, PCNs and GP practices on prescribing spend per patient",
          "Rank places on clinical prescribing measures",
          "Show Drug Tariff prices and price concessions with their cost to the NHS",
          "Summarise an ICB's prescribing finance position and benchmarks",
          "Return the headline of an ICB's monthly prescribing intelligence report",
          "Draft a shareable RxIQ dashboard for an area or medicine from a description"
        ],
        "websiteURL": "https://rxiq.co.uk/connect",
        "supportURL": "https://rxiq.co.uk/connect#support",
        "privacyPolicyURL": "https://rxiq.co.uk/privacy",
        "termsOfServiceURL": "https://rxiq.co.uk/terms",
        "defaultPrompt": [
          "Which ICBs spend the most on apixaban per 1,000 patients?",
          "How does Norfolk and Suffolk ICB rank on antibiotic prescribing measures?",
          "Is apixaban 5mg on price concession, and what is it costing the NHS?"
        ],
        "brandColor": "#0D6E6E",
        "composerIcon": "./assets/logo.png",
        "logo": "./assets/logo.png"
      },
      "review": {
        "demo_recording_url": "https://youtu.be/8SHIHB9nSa4",
        "test_cases": {
          "positive": [
            {
              "description": "Rank ICBs by spend per patient on one medicine",
              "prompt": "Which ICBs spend the most on apixaban per 1,000 patients?",
              "tools_triggered": "search, get_medicine",
              "expected_behavior": "Names the top ICBs by apixaban cost per 1,000 patients over the latest 12 months, with England's total spend for context, the data period and a link to the RxIQ medicine page."
            },
            {
              "description": "Clinical measures for an ICB",
              "prompt": "How does Norfolk and Suffolk ICB rank on antibiotic prescribing measures?",
              "tools_triggered": "search, get_measures",
              "expected_behavior": "Finds Norfolk & Suffolk ICB, then lists each antibiotics measure with the ICB's value, England's value and its rank out of 36, noting which direction is better, with links to RxIQ."
            },
            {
              "description": "Drug Tariff price and concessions for a pack",
              "prompt": "Is apixaban 5mg on price concession, and what is it costing the NHS?",
              "tools_triggered": "get_tariff_and_concessions",
              "expected_behavior": "Gives the current Drug Tariff price for apixaban 5mg tablets, the recent months with a price concession and their concession prices, and the estimated cost above tariff to the NHS, marking any estimated months, with a link to RxIQ."
            },
            {
              "description": "Monthly trend for a medicine in one ICB",
              "prompt": "Show the monthly cost of edoxaban prescribing in Norfolk and Suffolk ICB over the last 12 months.",
              "tools_triggered": "search, query_prescribing",
              "expected_behavior": "Returns edoxaban cost by month for Norfolk & Suffolk ICB over the latest 12 months of data, with the total and a link that opens the same view in RxIQ Analyse."
            },
            {
              "description": "Headline of an ICB intelligence report",
              "prompt": "What is the headline from the latest prescribing intelligence report for Birmingham and Solihull ICB?",
              "tools_triggered": "search, get_intelligence_report",
              "expected_behavior": "Gives the latest report's headline and summary for Birmingham & Solihull ICB, lists the sections it covers, and links to the full report on RxIQ."
            }
          ],
          "negative": [
            {
              "description": "Patient-level data is not held; the plugin should explain that it holds aggregate data only",
              "prompt": "Which patients at Holt Medical Practice are taking apixaban?"
            },
            {
              "description": "Individual clinical advice is out of scope; the plugin should not be used to make a treatment decision",
              "prompt": "Should I switch my patient from warfarin to apixaban?"
            },
            {
              "description": "Data outside NHS England primary care is not held; the plugin should say so rather than return English figures",
              "prompt": "How much do hospitals in Scotland spend on adalimumab?"
            }
          ]
        },
        "commerce": false,
        "commerce_description": "RxIQ does not sell products or process payments."
      },
      "publication": {
        "countries": [],
        "release_notes": "First release: prescribing queries by medicine, place and month; medicine and place summaries; clinical measures; Drug Tariff prices and concessions; ICB finance positions; ICB intelligence report headlines; dashboard drafts to view and save on rxiq.co.uk."
      },
      "apps": "./.app.json"
    }
  }
}